摘要
目的分析经皮冠状动脉介入治疗(PCI)前0.5 h心率>67次/min对急性ST段抬高型心肌梗死患者预后的影响。方法选取联勤保障部队第九八八医院心血管内科2019年1月至2019年12月收治的60例行PCI的急性ST段抬高型心肌梗死患者为研究对象,依据术前0.5 h中位心率(67次/min)分为高心率组(68~149次/min)与低心率组(40~67次/min)各30例,术后均随访2年。比较两组患者全因死亡率、Q波型心肌梗死发生率、心功能指标差异。结果低心率组全因死亡率、Q波型心肌梗死发生率低于高心率组,术后2年的心功能指标优于高心率组,差异有统计学意义(P<0.05)。结论PCI前0.5 h心率>67次/min的急性ST段抬高型心肌梗死患者全因死亡风险及Q波型心肌梗死发生风险显著增加,预后更差,故予以积极的干预和控制尤为重要。
Objective To analyze the impact of heart rate>67 beats/min 0.5 h before percutaneous coronary intervention(PCI)on the prognosis of patients with acute ST segment elevation myocardial infarction.Methods A total of 60 patients with acute ST-segment elevation myocardial infarction admitted to the Department of Cardiovascular Medicine of the Ninety-eighth Hospital of the Joint Security Force from January 2019 to December 2019 were selected for the study.According to the median heart rate(67 beats/min)at 0.5 h before surgery,they were divided into a high heart rate group(68 beats/min to 149 beats/min)and a low heart rate group(40 beats/min to 67 beats/min),with 30 patients each.All patients were followed up for 2 years.To compare the differences in all cause mortality,incidence of Q-wave myocardial infarction incidence,and cardiac function indicators between the two groups.Results The all-cause mortality rate and the incidence of Q-wave myocardial infarction in the low heart rate group were lower than those in the high heart rate group,and the cardiac function indicators were more superior to those in the high heart rate group at 2 years after surgery,with a statistically significant difference(P<0.05).Conclusion Patients with acute ST-segment elevation myocardial infarction with a heart rate>67 beats/min 0.5 h before PCI have a significantly increased risk of all-cause mortality and Q-wave myocardial infarction,and a worse prognosis.Therefore,active intervention and control are particularly important.
作者
马强
陈建辉
Qiang;CHEN Jianhui(Department of Cardiovascular Medicine,988th Hospital of Joint Logistic Support Force,Zhengzhou Henan 450000,China)
出处
《临床研究》
2023年第5期45-47,共3页
Clinical Research
